Joshua Disbrow | Chairman and CEO |
Richard Eisenstadt | CFO |
Jennifer Kim | Cantor Fitzgerald |
Good afternoon and thank you for joining us today for the Aytu Biopharma Financial Results and Business Update Call for the Fiscal Third Quarter Ended March 31st, 2021. With me this afternoon are Aytu's Chairman and Chief Executive Officer, Josh Disbrow; and Chief Financial Officer, Richard Eisenstadt. Aytu Biopharma issued a press release earlier today with the details of the company's operational and financial results for the fiscal third quarter. A copy of the press release is available on the News page of the company's website at aytubio.com. I'd like to remind everyone that today's call is being recorded.